# A Phase I Study of CREPT-618 in Locally Advanced HCC

> **NCT07364357** · PHASE1 · RECRUITING · sponsor: **Cancer Institute and Hospital, Chinese Academy of Medical Sciences** · enrollment: 13 (estimated)

## Conditions studied

- Hepatocellular Carcinoma (HCC)

## Interventions

- **GENETIC:** gene therapy

## Key facts

- **NCT ID:** NCT07364357
- **Lead sponsor:** Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-15
- **Primary completion:** 2026-08-15
- **Final completion:** 2027-09-15
- **Target enrollment:** 13 (ESTIMATED)
- **Last updated:** 2026-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07364357

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07364357, "A Phase I Study of CREPT-618 in Locally Advanced HCC". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT07364357. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*